Product Description
P-aminohippuric acid is an N-acylglycine that is the 4-amino derivative of hippuric acid; used as a diagnostic agent in the measurement of renal plasma flow. It has a role as a Daphnia magna metabolite. It is a conjugate acid of a p-aminohippurate. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Aminohippuric-acid)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Diagnostic Agent
Route of Administration: Oral,Injection
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Austria | Canada | Germany | India | Malaysia | Taiwan | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|